Blood-based assay shows promise for detecting IDH1.R132H-mutant gliomas
Glioma represents the most common central nervous system cancer in adults. The current classification scheme uses molecular alterations, particularly IDH1.R132H, to stratify lesions into distinct prognostic groups.